ストックスクリーナーアプリを入手
0.69
0.10%
0.0007
アフターアワーズ：
2.58
1.89
+273.91%
前日終値:
$0.6893
開ける：
$0.7065
24時間の取引高:
72,906
Relative Volume:
0.32
時価総額：
$7.41M
収益：
-
当期純損益:
$-3.28M
株価収益率:
-0.6631
EPS:
-1.0406
ネットキャッシュフロー:
$-4.80M
1週間 パフォーマンス:
-11.56%
1か月 パフォーマンス:
-2.10%
6か月 パフォーマンス:
-31.68%
1年 パフォーマンス:
-46.92%
1日の値動き範囲:
$0.6789
$0.749
1週間の範囲:
$0.66
$0.819
52週間の値動き範囲:
$0.63
$1.51
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
名前
Pharmacyte Biotech Inc
セクター
電話
(917) 595.2850
住所
3960 HOWARD HUGHES PARKWAY, LAS VEGAS
Compare PMCB vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| 2.24 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.90 | 2.52B | 0 | 0 | 0 | 0.00 |
GOODO
Gladstone Commercial Corporation
|
19.70 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
3.94 | 364.47M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
5.35 | 297.48M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
43.81 | 0 | 0 | 0 | 0 | 0.00 |
Pharmacyte Biotech Inc (PMCB) 最新ニュース
Director Weinstein receives 119,170 stock options at PharmaCyte Biotech (PMCB) - Stock Titan
Director at PharmaCyte Biotech (PMCB) gets 119,170 options - Stock Titan
PharmaCyte Biotech (PMCB) director awarded 119,170 stock options at $0.67 - Stock Titan
PharmaCyte Biotech (PMCB) director receives 119,170 stock options at $0.67 - Stock Titan
PharmaCyte Biotech Shareholders Approve Governance and Equity Actions - TipRanks
PharmaCyte Biotech (PMCB) wins approval for reverse split range and 2M new plan shares - Stock Titan
PMCB Stock Chart | PHARMACYTE BIOTECH INC (NASDAQ:PMCB) - ChartMill
Insider Sell: How liquid is PharmaCyte Biotech Inc stock2026 Setups & Safe Entry Momentum Tips - baoquankhu1.vn
PharmaCyte Biotech (PMCB) logs neutral Form 4 as 10% FEMASYS (FEMY) owner - Stock Titan
PharmaCyte Biotech (FEMY) reports 7.87% stake including warrants - Stock Titan
PharmaCyte Biotech, Inc. (PMCB) Q3 2026 10-Q Report: Financial Results, Stock Information, and SEC Filings - Minichart
PharmaCyte Biotech 10-Q: $0.0M Revenue, $(0.17) EPS (Q3), $(2.41) EPS (YTD) - TradingView
PharmaCyte Biotech (NASDAQ: PMCB) details Jan 2026 results and cash runway - Stock Titan
PharmaCyte Biotech delays quarterly report filing - MSN
Analyzing Prime Medicine (NYSE:PRME) & PharmaCyte Biotech (OTCMKTS:PMCBD) - Defense World
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
PharmaCyte Biotech (PMCB) seeks reverse split, equity plan boost at 2026 meeting - Stock Titan
Aug Catalysts: Can PharmaCyte Biotech Inc. stock weather global recessionWeekly Profit Summary & Safe Capital Growth Plans - Naître et grandir
PMCB Stock Jumps 25% After Company Sells Stake In Femasys - Stocktwits
PMCB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Technical Analysis - Intellectia AI
PharmaCyte Biotech (PMCB) seeks reverse split and 2M share plan boost at virtual meeting - Stock Titan
Day Trade: Can PharmaCyte Biotech Inc keep up with sector leadersJuly 2025 Trends & Free Long-Term Investment Growth Plans - baoquankhu1.vn
PharmaCyte Biotech Inc. (PMCB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading 5.9% Higher – Time to Buy? - Defense World
Volume Summary: What is SIM Acquisition Corp Is P E ratio telling usJuly 2025 Catalysts & Trade Opportunity Analysis Reports - baoquankhu1.vn
Dow Update: Is PharmaCyte Biotech Inc vulnerable to short sellersMarket Risk Summary & Verified Trade Idea Suggestions - baoquankhu1.vn
Is PharmaCyte Biotech Inc. trading at a discountWeekly Stock Report & Weekly High Momentum Picks - mfd.ru
Is PharmaCyte Biotech Inc. vulnerable to short sellersJuly 2025 Price Swings & Fast Momentum Stock Entry Tips - bollywoodhelpline.com
Dividend Watch: Is PharmaCyte Biotech Inc in a bullish channelJuly 2025 Short Interest & AI Driven Price Predictions - baoquankhu1.vn
PharmaCyte Biotech (OTCMKTS:PMCBD) Shares Down 4.3% – Time to Sell? - Defense World
Bull Run: Why PharmaCyte Biotech Inc stock attracts high net worth investorsInsider Selling & Weekly Breakout Watchlists - Bộ Nội Vụ
PharmaCyte Biotech stock surges following profitable exit from Femasys investment - MSN
Hedge Fund and Insider Trading News: Paul Singer, Steve Cohen, Israel Englander, Ray Dalio, Rokos Capital Management, Viking Global, PharmaCyte Biotech Inc (PMCB), Cloudflare Inc (NET), and More - Insider Monkey
Why PharmaCyte Biotech Inc. stock could see breakout soonJuly 2025 Retail & Daily Growth Stock Tips - Улправда
Why PharmaCyte Biotech Inc. stock appeals to analystsJuly 2025 Outlook & Technical Entry and Exit Tips - Улправда
Will PharmaCyte Biotech Inc. stock rally after Fed decisionsWeekly Stock Report & Low Drawdown Trading Strategies - ulpravda.ru
How currency fluctuations impact PharmaCyte Biotech Inc. stockEarnings Summary Report & Long-Term Safe Investment Ideas - ulpravda.ru
Will PharmaCyte Biotech Inc. stock keep outperforming rivals2025 Sector Review & Risk Controlled Stock Alerts - Улправда
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232 By Investing.com - Investing.com Nigeria
PMCB Stock Insider Trading Activity - Quiver Quantitative
Pharmacyte Biotech CEO Silverman buys $80k in shares By Investing.com - Investing.com Nigeria
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232 - Investing.com
Pharmacyte Biotech CEO Silverman buys $80k in shares - Investing.com
How institutional buying supports PharmaCyte Biotech Inc. stockEarnings Per Share Trends & Minimal Investment Trading Tips - ulpravda.ru
PharmaCyte Biotech (PMCB) Stock Analysis Report | Financials & Insights - Benzinga
Largest borrow rate increases among liquid names - TipRanks
Pharmacyte Biotech Inc (PMCB) 財務データ
収益
当期純利益
現金流量
EPS
0.49%
1.47%
大文字化:
|
ボリューム (24 時間):